Genmab AS (GMAB)
20.46
-0.30
(-1.45%)
USD |
NASDAQ |
Dec 24, 13:00
20.46
0.00 (0.00%)
After-Hours: 13:59
Genmab Market Cap: 12.99B for Dec. 24, 2024
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
Novo Nordisk AS | 387.86B |
Ascendis Pharma AS | 8.293B |
Galecto Inc | 6.401M |
Evaxion Biotech AS | 5.109M |
IO Biotech Inc | 59.29M |
Market Cap Related Metrics
PE Ratio | 19.44 |
PS Ratio | 4.616 |
PEG Ratio | 1.301 |
Price to Book Value | 2.718 |
Price to Free Cash Flow | 13.90 |
Price | 20.46 |
Earnings Yield | 5.14% |
PEGY Ratio | 1.301 |
Operating PE Ratio | 14.12 |
Normalized PE Ratio | 17.20 |